HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $18 Price Target

BriaCell Therapeutics Corp Ordinary Shares -1.72% Pre

BriaCell Therapeutics Corp Ordinary Shares

BCTX

2.28

2.28

-1.72%

0.00% Pre

HC Wainwright & Co. analyst Emily Bodnar reiterates BriaCell Therapeutics (NASDAQ: BCTX) with a Buy and maintains $18 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via